BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25514863)

  • 1. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).
    Schneider DT; Orbach D; Cecchetto G; Stachowicz-Stencel T; Brummel B; Brecht IB; Bisogno G; Ferrari A; Reguerre Y; Godzinski J; Bien E; Calaminus G; Göbel U; Patte C
    Eur J Cancer; 2015 Mar; 51(4):543-550. PubMed ID: 25514863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.
    Gui T; Cao D; Shen K; Yang J; Zhang Y; Yu Q; Wan X; Xiang Y; Xiao Y; Guo L
    Gynecol Oncol; 2012 Nov; 127(2):384-9. PubMed ID: 22850410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature.
    Koo J; Garrington TP; Kerr K; Treece AL; Cost CR
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28621. PubMed ID: 32729194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
    Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
    Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
    Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
    Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
    J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes among patients with sex cord stromal tumour of ovary: experience from Pakistan.
    Sarwar S; Siddiqui N; Ather S; Hannan A; Ali Syed A; Zafar W
    J Ayub Med Coll Abbottabad; 2014; 26(3):389-92. PubMed ID: 25671955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
    Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G
    Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian sex cord-stromal tumors--a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry.
    Schneider DT; Jänig U; Calaminus G; Göbel U; Harms D
    Virchows Arch; 2003 Oct; 443(4):549-60. PubMed ID: 12910419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian sex cord-stromal tumors in children and adolescents.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Selle B; Sternschulte W; Harms D; Göbel U
    J Clin Oncol; 2003 Jun; 21(12):2357-63. PubMed ID: 12805338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on Sertoli-Leydig Cell Tumours of the Ovary.
    Muscat C; Calleja-Agius J
    Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study.
    Fresneau B; Orbach D; Faure-Conter C; Verité C; Castex MP; Kalfa N; Martelli H; Patte C
    Pediatr Blood Cancer; 2015 Dec; 62(12):2114-9. PubMed ID: 26206391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings.
    Mooney EE; Nogales FF; Bergeron C; Tavassoli FA
    Histopathology; 2002 Aug; 41(2):110-7. PubMed ID: 12147087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.
    Wang G; Zhang R; Li C; Chen A
    J Ovarian Res; 2021 Nov; 14(1):150. PubMed ID: 34736487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
    Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
    J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian sex cord-stromal tumors in children and adolescents.
    Schneider DT; Calaminus G; Harms D; Göbel U;
    J Reprod Med; 2005 Jun; 50(6):439-46. PubMed ID: 16050568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
    Zhang HY; Zhu JE; Huang W; Zhu J
    Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
    Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.